Literature DB >> 2794973

Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus.

L McLain1, N J Dimmock.   

Abstract

The lungs of C3H/HeMg mice infected with a lethal dose of the influenza virus A/WSN (H1N1) contained antibody to the viral neuraminidase glycoprotein but not to the haemagglutinin (HA). When coinoculated with a life-saving amount of defective interfering (DI) WSN, lungs were found to contain both anti-neuraminidase and haemagglutination-inhibiting (HI) antibodies which peaked at 3 and 5 days post-infection (p.i.), respectively. Mice coinoculated with WSN and beta-propiolactone-inactivated DI WSN had only anti-neuraminidase antibody in the lungs. The HI activity was unusual in that there was no detectable neutralizing activity. The HI activity has been affinity-purified by adsorption to and elution from WSN HA and consisted entirely of IgG, comprising isotypes IgG1, IgG2a and IgG2b. The antibody was specific for WSN HA, of low activity and had disappeared from the lungs by 20 days p.i. Transfer of affinity-purified HA-specific, non-neutralizing antibody to mice 24 h before infection with WSN alone protected 60% from death. We conclude that the antibody contributes significantly to the life-saving activity of DI WSN virus and that the ability to stimulate such antibody represents a novel property of this DI virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794973     DOI: 10.1099/0022-1317-70-10-2615

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

Review 1.  Insights into neutralization of animal viruses gained from study of influenza virus.

Authors:  M C Outlaw; N J Dimmock
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

2.  An influenza haemagglutinin-specific IgG enhances class I MHC-restricted CTL killing in vitro.

Authors:  L McLain; N J Dimmock
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

3.  Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model.

Authors:  Adrianus C M Boon; Jennifer deBeauchamp; Scott Krauss; Adam Rubrum; Ashley D Webb; Robert G Webster; Janet McElhaney; Richard J Webby
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

Review 4.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

5.  Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.

Authors:  Jason R Wilson; Wen-Pin Tzeng; April Spesock; Nedzad Music; Zhu Guo; Robert Barrington; James Stevens; Ruben O Donis; Jacqueline M Katz; Ian A York
Journal:  Virology       Date:  2014-05-10       Impact factor: 3.616

Review 6.  Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.

Authors:  Jean-Louis Excler; Julie Ake; Merlin L Robb; Jerome H Kim; Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2014-06-11

7.  Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.

Authors:  F Verrier; A Nádas; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies.

Authors:  J Arikawa; J S Yao; K Yoshimatsu; I Takashima; N Hashimoto
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody.

Authors:  J P Wong; L L Stadnyk; E G Saravolac
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

10.  Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse.

Authors:  D J Morgan; N J Dimmock
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.